Negocios · 10/6/19941 min de lectura
The Use of Immunohistochemical Devices in the Clinical Care of Patients; Notice of Public Workshop
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing a public workshop to discuss the use of immunohistochemical devices in the clinical care of patients. In addition, FDA is interested in obtaining comments on the regulation of products used in immunohistochemical tests.